SGRX
Sangrix Inc.
SGRX | NASDAQ
$0.75
+$0.02 (+2.25%)
Nov 2, 2026, 11:22 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 | FY 2020 Jun 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 39.5K | 2.89M | 6.26M | 192.35K | n/a | 24.25M |
Cost of Revenue | n/a | 3.83M | 10.83M | 403.38K | n/a | 22.22M |
Gross Profit | n/a | -945.2K | -4.57M | -211.03K | n/a | 2.03M |
Operating Income | -2.99M | -14.84M | -28.3M | -6.06M | -3.47M | -2.61M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 2.45K |
Pretax Income | -4.37M | -18.28M | -28.22M | -5.34M | -3.64M | -3.14M |
Net Income | -4.39M | -17.53M | -28.22M | 3.24M | -45.61M | -4.88M |
Selling & General & Admin | 3.03M | 3.89M | 2.98M | 5.85M | 3.47M | 4.64M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 10M | 20.76M | n/a | n/a | n/a |
Operating Expenses | 3.03M | 13.89M | 23.74M | 5.85M | 3.47M | 4.64M |
Interest Expense | 455.19K | 497.77K | 227.38K | 54.14K | 156.05K | 529.51K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.03M | 17.72M | 34.57M | 6.25M | 3.47M | 26.86M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 223.17K |
Shares Outstanding (Basic) | 77.02K | 17.47K | 10.93K | 6.72K | 3.69K | 2.66K |
Shares Outstanding (Diluted) | 77.02K | 17.47K | 10.93K | 6.72K | 3.69K | 2.66K |
EPS (Basic) | -84.85 | -1K | -2.58K | 481.95 | -12.37K | -1.83K |
EPS (Diluted) | -84.85 | -1K | -2.58K | 481.95 | -12.37K | -1.83K |
EBITDA | -2.99M | -16.89M | -22.63M | -5.78M | -3.48M | -2.61M |
EBIT | -2.99M | -17.79M | -27.99M | -6.06M | -3.48M | -2.61M |
Depreciation & Amortization | n/a | 900.94K | 5.36M | 276.76K | n/a | 1.58K |
Add to Watchlist
Select watchlists to add or remove SGRX